News of Oxford University and AstraZeneca‘s successful COVID-19 vaccine trial is inspiring increased optimism within the medical community.
“We need billions of doses. And different vaccines have different upsides and downsides. Like the newest one we heard about yesterday, AstraZeneca. It’s easier to manufacture. So there (are) more doses that can be made, and probably at less cost,” said Joseph Eron, MD, the chief of the division of infectious diseases at UNC’s School of Medicine.
Watch and read the news story at WTVD 11 News.